Oct 31, 2023 | COVID-19, Dental, Medical, News, Pharmacy, Premiums, Prescription, Primary Care, Specialist, Telehealth, Vision
Average annual premiums for U.S. employer-sponsored single and family health insurance coverages both rose 7% in 2023, according to a survey conducted by KFF and published in Health Affairs. While the increase is higher than in recent years, it is generally in line...
Oct 16, 2023 | Cost Savings, MedBen Rx, Pharmacy, Prescription, Rx Costs, Savings
From a new report published by the U.S. Department of Health & Human Services: “Over the period from January 2022 to January 2023, more than 4,200 drug products had price increases, of which 46 percent were larger than the rate of inflation. The average drug...
Aug 7, 2023 | Access solutions, Case Studies, Cost Savings, Drug costs, Limited use HRA, MedBen Rx, Patient advocacy program, Pharmacy, Rx Costs, Savings, Specialty Drugs
With specialty drugs now making up about half of total drug spending – and poised to go even higher as more new specialty drugs roll out every year – the need for workable access solutions grows. Fortunately, MedBen Rx has them. Our unique approach incorporates a...
Jul 21, 2023 | Diabetes, Medicare, Ozempic, Pharmacy, Prescription, Research, Trulicity, Weight loss
A Kaiser Family Foundation (KFF) analysis of the 10 top-selling prescription drugs under Medicare Part D offers an interesting snapshot of pharmacy spend. The drugs in question comprised less than 1% of all covered drugs in 2021, but made up approximately 22% of total...
Jul 11, 2023 | Brand Name Drugs, Generic Drugs, MedBen Rx, Pharmacy, Pharmacy Benefits Manager (PBM), Prescription, Rx Costs, Savings, Specialty Drugs, Transparency, Value
A new playbook from the National Alliance of Healthcare Purchaser Coalitions lists the top 10 concerns employer health plans have with pharmacy benefit managers (PBMs): Promoting drugs with higher prices when lower-price options are availableOffering preferred...
Jun 15, 2023 | Obesity, Ozempic, Pharmacy, Prescription, Rx Costs, Semaglutide, Wegovy, Weight loss
Obesity drugs are becoming big business, with a correspondingly big price tag. And with these drugs regularly making headlines, questions about whether or not health plans should cover them grow louder. The highest-profile obesity drug is semaglutide, sold under the...
